All Episodes
Citeline Podcasts — 625 episodes · page 1 of 7
Digital Health Roundup: Oura Plans IPO, FDA’s Home Health, Digital Tools For Alzheimer’s Detection
Strategic Intent: Next‑Generation Cancer Vaccines And Nouscom’s Strategy For Interception And Personalization
Scaling Self-Care In Asia Pacific, With APSMI's Rachmadi Joesoef and Anama O'Reilly
Drug Fix: Increasing US FDA Leadership Stability And Where All The Adcomms Have Gone
Strategic Intent: Evolving Requirements Of Life Sciences Leadership
Drug Fix: US FDA Commissioner Nominee Heidi Overton’s Resume And COVID-19 Vaccine Trial Changes
Proof Of Concept: How A Charity Bridges Lab And Clinic
Off-Patent, On Record: A Story Of Patients Fighting For Accessible Cystic Fibrosis Treatment
Strategic Intent: Beyond The Breakthrough - From Approval To Adoption
Making The Case For Switch, With AESGP’s Christelle Anquez-Traxler
Advancing CNS Drug Development Through AI, New Approach Methodologies and Regulatory Innovation
ZS On How AI is Reshaping The Patient's Approach to Care Delivery - a View From the US, China and Germany
Drug Fix: MFN Finds Mid-Size Companies And More Vaccine Policy Moves
【3分で解説 #世界のファーマ】第30回 米国、ジェネリック関税に国内外から懸念／BMSとAZ合併の噂 (Japanese-language podcast) Aug. 28, 2026
Videocast: Goodwin’s Sophie McGrath – A Legal View Of Healthtech And Biopharma Trends
Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency
Bonus Episode: Inside Endocyclic’s Precision Peptide Strategy For Endometriosis Diagnosis And Treatment
Strategic Intent: The Rise Of Mid-Cap Dealmakers
Building The GLP-1 Companion Category, With Beverley Law And Martina Gripp
Drug Fix: Understanding The PDUFA VIII Revenue Cut And GDUFA IV Name Change
The State of Play in Biotech and the Decisions Shaping the Industry
Strategic Intent: First-in-class, two markets: Annexon’s GBS and GA Strategies
Drug Fix: Regulatory Nationalism And US FDA’s IND Reforms
Proof of Concept - AI in Drug Discovery
Digital Health Roundup: CE Mark For Vision-Restoring Implant, AI Chatbot Rules, MS Deal
Podcast: China's Evolving Role in Global Clinical Development
Off-Patent, On Record: View Through The Journalist's Lens With Generics Bulletin's Dave Wallace
Realising Growth Through Pharmacy, With Simon-Kucher’s Christian Danelund And Chris Rebholz
European Biotech At A Crossroads: How Can It Stay Competitive? Video Podcast
The Next Era Of Oncology Biosimilars
How ElevateBio Is Betting On Every Gene Editing Modality At Once
The Generics Bulletin Podcast: Summer Conferences
Drug Fix: US FDA Undoes Podium Policy, Lessons From CDC, ASPR Confirmation Hearings
Eisai Video Interview AT AAIC Alzheimer's Conference, July 15
Scrip Deals Podcast, July 2026, with Dr. Bruce Leuchter
The Dos And Don’ts Of Health Literacy, With Self-Care Forum’s Trevor Gore
Drug Fix: New Complete Response Letter, DTC Ad Regulations And A Potential US FDA Reorg
Tonix’s Bet On Monoclonal Prevention Of Lyme Disease
Patient Capital And Regulatory Resolve: Dr Reddy’s Chief On Building India's Innovation Backbone
China’s New Data Protection Framework: Periods And Impact
The Economic and Social Value Of Probiotics, With IPA Europe’s Rosanna Pecere
‘빅 드럭’ 시대 본격화…글로벌 제약 매출, 2조 달러 넘을 듯 (Korean-language podcast) June 29, 2026
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 29, 2026
Scrip's Five Must-Know Things - June 29, 2026
Drug Fix: US FDA’s New Guidance On One-Trial Efficacy Standard And IND Reform Pilot
Elevate Clinical Operations into a Board Level Strategic Advantage
The Insight Room: Catching the Deadliest Cancer Earlier - Inside the PRECEDE–Azenta Partnership
The Yescarta Launch Examined
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 22, 2026
Scrip's Five Must-Know Things - June 22, 2026
The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin
Philips' Shez Partovi on increasing AI adoption, clinicians' attitudes and the hybrid care model
The Socio-Economic Case For Prevention, With Deloitte’s Elizabeth Hampson
Drug Fix: WuXi vs. the Pentagon, New Advertising Citations, And FDA Explores The Limits Of AI
【3分で解説 #世界のファーマ】第29回【トランプ関税で注目】米国、医薬品不足のいま (Japanese-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 15, 2026
Scrip's Five Must-Know Things - Jun. 15, 2026
플랙쉽 파이오니어링, 한국서 장기적 파트너십, 바이오 생태계 성장 모색 (Korean-language podcast)
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 8, 2026
Scrip's Five Must-Know Things - June 1, 2026
Scrip's Five Must-Know Things - June 8, 2026
Drug Fix: SCOTUS Rules On Generic Skinny Labels, US FDA’s NPV Faces Uncertain Future
Ambu CEO Britt Meelby Jensen on EU competitivity and compromise
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) June 1, 2026
Decoding Cell Stress at Soley Therapeutics
Drug Fix: Potential Nondisclosure Agreements For US FDA Staff, Hiring Threatens User Fee Reductions
Scrip's Five Must-Know Things - May 25, 2026
Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 25, 2026
Drug Fix: What’s Next For US FDA After Senior Leadership Purge
MHRA’s Rob Reid updates on timings for CE marking, pre-market SI and possible EU MDR outcomes
Redefine Modern Biotech Through Smarter Boards, Stronger ROI, and China's Rise
Europe’s Evolving Role in Global Clinical Trials
Scrip Deals Podcast: An Interview With Jeremy Levin
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 18, 2026
Scrip's Five Must-Know Things - May 18, 2026
Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner
ABHI's Steve Lee on the UK MHRA's frictionless regulatory future for the UK
The Generics Bulletin Podcast: Biosimilars Conference Report And Big M&A Deals
Kurma’s €215m Fund And What It Says About European Funding Environment
The Scrip Awards Podcast - Call For Entries 2026, New AI Category, Triana Interview
Podcast: Inside Arcutis with CEO Frank Watanabe
How Agentic AI Could Reshape Consumer Health, With IQVIA’s Volker Spitzer
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 11, 2026
Scrip's Five Must-Know Things - May 11, 2026
Drug Fix: US FDA’s Makary Pressured To Resign, Continues Hiring, Reform Efforts
Forum chief Gwyn Tudor puts the case for medtech development in Wales
Drug Fix: The New Acting US FDA Biologics Center Director, SCOTUS Eyes Generic Drug Policy
Carna Health On Closing the Gap in CKD Prevention
What To Expect After China’s First siRNA Firm Went Public
Five-Minute Podcast: Chris Jones On Wales' Life Sciences Innovation Hub
Cracking China's Consumer Health Market, With QIVA Global's Ellie Adams
Genyro’s Adrian Woolfson on Artificial Biological Intelligence and Genome Writing
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 27, 2026
Scrip's Five Must-Know Things - Apr. 27, 2026
PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗？(Chinese-language podcast)
Redefine Modern Biotech Through Smarter Boards, Stronger ROI, and China's Rise
Scrip M&A Podcast with Cooley Attorneys Kevin Cooper and Bill Roegge.
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Apr. 21, 2026
Scrip's Five Must-Know Things - Apr. 21, 2026